These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
56 related articles for article (PubMed ID: 506780)
1. [Analysis of dependence of pharmacological activity of new pyrimidine compounds on their chemical structure. I. General pharmacological properties]. Oledzka K Acta Pol Pharm; 1979; 36(1):95-102. PubMed ID: 506780 [No Abstract] [Full Text] [Related]
8. Screening pharmacological studies of four dihydroisoquinoline derivatives. Stoychev T; Koleva M; Orahovats A; Trifonov L Acta Physiol Pharmacol Bulg; 1979; 5(3):82-90. PubMed ID: 539451 [TBL] [Abstract][Full Text] [Related]
9. The effect of alkyl substitution in drugs. XX. Some pharmacological investigations into a series of 1-(o-alkylphenyl)-2-methyl and 1-(o-alkylphenyl)-2-ethylcyclohexanols. Timmerman H; Mulder D; Nauta WT Arzneimittelforschung; 1969 Aug; 19(8):1254-7. PubMed ID: 4390181 [No Abstract] [Full Text] [Related]
10. Some observations on the pharmacological effects of salbutamol, with particular reference to the cardiovascular system. Nayler WG Postgrad Med J; 1971 Mar; 47():Suppl:16-21. PubMed ID: 5572512 [No Abstract] [Full Text] [Related]
11. General pharmacological profile of the new cognition-enhancing agent nefiracetam. Kitano Y; Makino M; Usui C; Takasuna K; Kasai Y; Hirohashi M; Tamura K; Takayama S; Kojima H; Iizuka H Arzneimittelforschung; 1994 Feb; 44(2A):199-210. PubMed ID: 8018090 [TBL] [Abstract][Full Text] [Related]
12. [Difference of tolerances to isoprenaline between tracheal and vascular smooth muscles and cardiac conduction system in guinea pigs]. Zhao SJ; Sun GL; Cao YS Zhongguo Yao Li Xue Bao; 1990 May; 11(3):210-3. PubMed ID: 1965090 [TBL] [Abstract][Full Text] [Related]
13. A comparison of the pharmacological properties of Clostridium botulinum type C1 and C2 toxins. Simpson LL J Pharmacol Exp Ther; 1982 Dec; 223(3):695-701. PubMed ID: 6292397 [No Abstract] [Full Text] [Related]
14. [4-[Benzyl-(2-dimethylaminoethyl)amino]pyrimidine compounds with selective antagonistic activity against H1-histamine receptors]. Mossini F; Maggiali C; Morini G; Impicciatore M; Morini G; Molina E Farmaco Sci; 1984 Mar; 39(3):189-99. PubMed ID: 6143687 [TBL] [Abstract][Full Text] [Related]
15. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries. Nielsen-Kudsk JE Dan Med Bull; 1996 Dec; 43(5):429-47. PubMed ID: 8960816 [TBL] [Abstract][Full Text] [Related]
16. General pharmacological properties of the new vasodilator flosequinan. Ikezono K; Fujita S; Umezato M; Hosoki E; Toba Y; Kusunoki A; Shintani S Arzneimittelforschung; 1992 Oct; 42(10):1200-11. PubMed ID: 1472141 [TBL] [Abstract][Full Text] [Related]
17. Tiapamil, a new calcium antagonist. 1. Demonstration of calcium antagonistic activity and related studies. Eigenmann R; Blaber L; Nakamura K; Thorens S; Haeusler G Arzneimittelforschung; 1981; 31(9):1393-401. PubMed ID: 7197945 [TBL] [Abstract][Full Text] [Related]
18. [Physiology of the coronary circulation as a basis for evaluation of coronary dilators]. Lochner W Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):127-44. PubMed ID: 4979631 [No Abstract] [Full Text] [Related]
19. [Relationship between pharmacological effect and chemical structure of new pyrimidine derivatives. II. Effect on various hemodynamic and biochemical parameters]. Oledzka K Acta Pol Pharm; 1979; 36(2):251-8. PubMed ID: 532681 [No Abstract] [Full Text] [Related]